These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 189923)

  • 1. Phase I and II evaluation of cytembena in disseminated epithelial ovarian cancers and sarcomas.
    Baker LH; Samson MK; Izbicki RM
    Cancer Treat Rep; 1976 Sep; 60(9):1389-91. PubMed ID: 189923
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of cytembena in patients with advanced ovarian and breast cancer.
    Falkson HC; Falkson G
    Cancer Treat Rep; 1976 Nov; 60(11):1655-8. PubMed ID: 1037286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with advanced ovarian carcinoma treated with Penberol.
    Novotná J; Andrysek O; Kobilková J; Laurová L
    Neoplasma; 1983; 30(2):245-50. PubMed ID: 6302531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tissue reaction in ovarian carcinoma after cyclophosphamide (Endoxan) therapy].
    Engeler V; Hanski W
    Pathol Microbiol (Basel); 1969; 33(3):153-60. PubMed ID: 5350583
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancer.
    Blackledge G; Lawton F; Buckley H; Crowther D
    Cancer Treat Rep; 1984 Mar; 68(3):549-50. PubMed ID: 6200221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy for ovarian cancer].
    Lindell A
    Lakartidningen; 1968 Mar; 65(11):1120-2. PubMed ID: 5743130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined chemotherapy of ovarian cancer with special reference to carboquone].
    Sugimori H; Kidera Y; Matsuyama T
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):66-71. PubMed ID: 6307172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II clinical trial of cytembena. Clinical screening group of E.O.R.T.C.
    Biomedicine; 1977 Dec; 26(6):392-5. PubMed ID: 342004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):581-3. PubMed ID: 1243107
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intratumor chemotherapy of patients with cancer of the ovaries].
    Vinokurov VL; Mitrokhina MV
    Vopr Onkol; 1983; 29(8):58-61. PubMed ID: 6310891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytoval therapy in advanced ovarian neoplasms].
    Tatra G; Breitenecker G
    Osterr Z Onkol; 1974; (3-4):66-70. PubMed ID: 4480681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phase II study of carboplatin in ovarian cancer].
    Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2291-6. PubMed ID: 3044275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for advanced ovarian cancer: a prospective randomized trial comparing hexamethylmelamine and cyclophosphamide to doxorubicin and cyclophosphamide.
    Schwartz PE; Lawrence R; Katz M
    Cancer Treat Rep; 1981; 65(1-2):137-41. PubMed ID: 6261948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in advanced ovarian cancer.
    Schein PS
    Geriatrics; 1973 Dec; 28(12):89-95. PubMed ID: 4128004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods of optimizing and objective criteria for evaluating the efficacy of chemo-surgical treatment of malignant epithelial tumors of the ovaries].
    Nechaeva ID; Vinokurov VL; Iurkova LE; Kotova DG; Aĭnbinder NM; Livshits MA; Zel'dovich DR; Mitrokhina MV
    Vopr Onkol; 1990; 36(8):992-5. PubMed ID: 2171227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of results of monochemotherapy of ovarian cancer with special reference to long-term survival].
    Sablińska B; Cześnin K; Ploch E
    Nowotwory; 1984; 34(3):229-35. PubMed ID: 6099543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results obtained in 6 cases of tumors treated with sarkomycin (an antitumoral antibiotic)].
    Sezer R
    Turk Tip Cemiy Mecm; 1966 Mar; 32(3):131-40. PubMed ID: 4287509
    [No Abstract]   [Full Text] [Related]  

  • 18. [1st report on programmed chemotherapy of ovarian carcinoma].
    Frank S; Richter K; Ehrhart H; Penning W; Meister P; Schmidt D; Götz A
    Fortschr Med; 1975 Oct; 93(28):1309-12. PubMed ID: 1228086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II evaluation of cytembena (NSC-104801) in patients with advanced ovarian carcinoma resistant to alkylating agents: brief communication.
    Edmonson JH; Decker DG; Malkasian GD; Webb MJ; Jorgensen EO
    J Natl Cancer Inst; 1977 Dec; 59(6):1619-20. PubMed ID: 579188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.